GeneDx Holdings Corp. (WGS NASDAQ) stock market data APIs
$34.5538
2.42(7%)
as of May 5, 2026
Try our APIs with
free plan!
GeneDx Holdings Corp. Financial Data Overview
Price chart is built with
Anychart
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
Prev. Close
34.5538
Open
36.9763
High
37.3338
Low
32.9072
52 wk Range
32.84-170.87
Market Cap
2 016 M
Shares Outstanding
29 676 K
Revenue
428 M
EPS
0.14
Beta
2.072
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with GeneDx Holdings Corp. (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get GeneDx Holdings Corp. data using free add-ons & libraries
Get GeneDx Holdings Corp. Fundamental Data
GeneDx Holdings Corp. Fundamental data includes:
- Net Revenue: 428 M
- EBITDA: 12 652 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-02-23
- EPS/Forecast: 0.0886
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
GeneDx Holdings Corp. News
New
WGS: GeneDX Shares Plummet Over 45%; Investors Should Contact Block & Leviton to Potentially Recover Money Through The Firm’s Investigation
BOSTON, May 05, 2026 (GLOBE NEWSWIRE) -- Block & Leviton is investigating GeneDX Holdings Corp. (NYSE: WGS) for potential securities law violations. Investors who have lost money in their GeneDX Hol...
Why GeneDX Stock Is Plummeting Today
GeneDX(NASDAQ: WGS) stock is getting crushed in Tuesday's trading. The biotech company's share price was down 48.7% as of 11 a.m. ET. GeneDX published its first-quarter results after yesterday's mark...
GeneDx Holdings Corp. (WGS) Reports Q1 Loss, Lags Revenue Estimates
GeneDx Holdings Corp. (WGS) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to earnings of $0.28 per share a year ago. These fig...
GeneDx plummets on lower 2026 guidance, Q1 misses
[First Quarter Q1 Profits Stock Trading Chart 3D Background] * GeneDx (WGS [https://seekingalpha.com/symbol/WGS]) is down ~42% in after-hours trading Monday after revising down its 2026 guidance fo...
Get GeneDx Holdings Corp. fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
